Activity of Pan-Class I Isoform PI3K/mTOR Inhibitor PF-05212384 in Combination with Crizotinib in Ovarian Cancer Xenografts and PDX

Engelman; Fry; Samuels; Djordjevic; Foster; Zhao; LoPiccolo; Baldo; Abraham; Motzer; Yao; Furman; Gopal; Hennessy; Fruman; Yap; Lai; Birchmeier; Maroun; Ricci; Ricci; Zamai; Krumbach; Turke; Chen; Tang; Liu

Activity of Pan-Class I Isoform PI3K/mTOR Inhibitor PF-05212384 in Combination with Crizotinib in Ovarian Cancer Xenografts and PDX

Authors: Engelman
Fry
Samuels
Djordjevic
Foster
Zhao
LoPiccolo
Baldo
Abraham
Motzer
Yao
Furman
Gopal
Hennessy
Fruman
Yap
Lai
Birchmeier
Maroun
Ricci
Ricci
Zamai
Krumbach
Turke
Chen
Tang
Liu
Publication date
Publisher: 'Elsevier BV'
Doi: DOI:10.1016/j.tranon.2016.08.011

Abstract

Abstract is not available.

Similar works

Full text

Crossref

Provided original full text link

Last time updated on 4/1/2019

This paper was published in Crossref.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.